Trial Details
COMPLETEDBasic Information
| Clinical ID | c4553 |
|---|---|
| Identifier | NCT00336492 |
| Trial Title | A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | BIOLOGICAL: infliximab|BIOLOGICAL: infliximab|BIOLOGICAL: infliximab|BIOLOGICAL: infliximab |
Participant Information
| Sponsor | Centocor, Inc. |
|---|---|
| City | Birmingham |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2006-09 |
|---|---|
| Primary Completion Date | 2009-05 |
| Completion Date | 2010-04 |